当前位置:首页 - 行情中心 - 步长制药(603858) - 财务分析 - 现金流量表

步长制药

(603858)

  

流通市值:175.31亿  总市值:175.31亿
流通股本:11.06亿   总股本:11.06亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,649,327,706.7713,257,913,278.6110,091,889,612.096,918,544,864.45
收到的税费返还12,483.6816,924,718.4210,208,921.691,092,555.65
收到其他与经营活动有关的现金99,929,709.9589,124,591.41198,185,806.69189,791,604.14
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,749,269,900.413,363,962,588.4410,300,284,340.477,109,429,024.24
购买商品、接受劳务支付的现金636,791,962.374,053,194,949.163,028,269,673.611,441,105,549.67
支付给职工以及为职工支付的现金266,768,562.251,049,899,021.37821,439,234.26530,008,137.7
支付的各项税费497,302,115.381,835,743,106.431,509,380,523.851,144,039,967.48
支付其他与经营活动有关的现金1,274,292,298.486,620,730,737.715,352,995,948.53,726,412,139.75
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,675,154,938.4813,559,567,814.6710,712,085,380.226,841,565,794.6
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额74,114,961.92-195,605,226.23-411,801,039.75267,863,229.64
二、投资活动产生的现金流量:
收回投资收到的现金-400,000,000380,000,000-
取得投资收益收到的现金-11,775,592.4412,713,126.699,324,015.47
处置固定资产、无形资产和其他长期资产收回的现金净额12,3602,400,034.231,800,312.61229,554.61
处置子公司及其他营业单位收到的现金净额431.69---
收到的其他与投资活动有关的现金909,074.8219,569,897.4918,946,633.17312,937,222.84
投资活动现金流入的平衡项目0000
投资活动现金流入小计921,866.51433,745,524.16413,460,072.47322,490,792.92
购建固定资产、无形资产和其他长期资产支付的现金87,326,830.66529,915,280.11386,058,268.39249,275,717.15
投资支付的现金-71,630,00067,500,00030,000,000
支付其他与投资活动有关的现金-200,579.51200,149.43200,149.43
投资活动现金流出的平衡项目0000
投资活动现金流出小计87,326,830.66601,745,859.62453,758,417.82279,475,866.58
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-86,404,964.15-168,000,335.46-40,298,345.3543,014,926.34
三、筹资活动产生的现金流量:
吸收投资收到的现金2,200,0004,288,2451,520,000200,000
其中:子公司吸收少数股东投资收到的现金2,200,0004,288,2451,520,000200,000
取得借款收到的现金947,214,9341,455,458,1861,343,370,0001,021,800,000
收到其他与筹资活动有关的现金943,757.7752,570,072.881,856,403.0916,969,888.26
筹资活动现金流入平衡项目0000
筹资活动现金流入小计950,358,691.771,512,316,503.881,346,746,403.091,038,969,888.26
偿还债务支付的现金409,903,582.461,297,271,264.461,265,671,264.46827,645,864.46
分配股利、利润或偿付利息支付的现金33,430,014.711,212,360,949.81,181,001,038.1456,539,864.68
其中:子公司支付给少数股东的股利、利润-18,097,066.1317,480,584.93-
支付其他与筹资活动有关的现金174,529,184.0468,071,951.4195,493,656.86110,609,721.34
筹资活动现金流出平衡项目0000
筹资活动现金流出小计617,862,781.212,577,704,165.672,542,165,959.46994,795,450.48
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额332,495,910.56-1,065,387,661.79-1,195,419,556.3744,174,437.78
四、汇率变动对现金及现金等价物的影响-21,288.819,833.5118,289.2720,599.11
现金及现金等价物净增加额平衡项目000-0.01
五、现金及现金等价物净增加额320,184,619.52-1,428,983,389.97-1,647,500,652.2355,073,192.86
加:期初现金及现金等价物余额691,586,636.92,121,316,547.862,121,316,547.862,121,316,547.86
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,011,771,256.42692,333,157.89473,815,895.662,476,389,740.72
补充资料:
净利润-151,865,198.31-683,581,016.15
资产减值准备-700,721,937.96-9,457,187.04
固定资产和投资性房地产折旧-377,805,154.62-189,221,417.01
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-377,805,154.62-189,221,417.01
无形资产摊销-198,681,334.3-96,197,382.69
长期待摊费用摊销-6,781,108.58-4,160,695.97
处置固定资产、无形资产和其他长期资产的损失--1,529,515.21--16,168.81
固定资产报废损失-4,002,320.61-91,992.47
公允价值变动损失-2,356,116.14--1,178,058.08
财务费用-91,108,018.66-35,099,430.06
投资损失--21,292,517.55--19,373,338.4
递延所得税--143,808,640.62--64,068,645.43
其中:递延所得税资产减少--146,814,798.84--74,561,748.63
递延所得税负债增加-3,006,158.22-10,493,103.2
存货的减少--1,185,790,218.05--173,578,009.06
经营性应收项目的减少-83,676,550.26--183,628,017.25
经营性应付项目的增加--493,591,132.15--308,655,922.88
现金的期末余额-692,333,157.89-2,476,389,740.72
减:现金的期初余额-2,121,316,547.86-2,121,316,547.86
公告日期2024-04-262024-04-262023-10-282023-08-26
审计意见(境内)标准无保留意见
TOP↑